Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

The Lucrative Growth of Investing in Intuitive Surgical

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
IT-Healthcare
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Investing in Intuitive Surgical (NASDAQ: ISRG) has been a game-changer for those who took the leap 10 years ago. With $1000 invested back then, it would now be worth an impressive $8,078.92, thanks to the stock’s current price of $389.67. This translates to an annualized outperformance of 12.52% and an average return of 23.17% over the past decade, showcasing the power of compounded returns on wealth accumulation.

For those who jumped on board in 2014 with a $1000 investment, the growth would be even more staggering, reaching $2,434,188.68 by March 13, 2024, a remarkable return of 540.6%. The current price per share stands at $270.46, indicating the company’s consistent growth trajectory.

Intuitive Surgical, Inc. is a pioneer in robotic-assisted products like the da Vinci surgical system, revolutionizing minimally invasive surgery and improving clinical outcomes. With a market capitalization of $138.12 billion, the company’s stock price is on an upward trend, with analysts forecasting an average price target of $416.89, representing a 6.39% upside potential.

In conclusion, investing in Intuitive Surgical has proven to be a lucrative decision, with substantial returns and strong market performance over the past decade.

Intuitive Surgical Inc. (ISRG) Stock Price Analysis: Potential for Growth Despite Recent Drop

On March 13, 2024, Intuitive Surgical Inc. (ISRG) experienced a slight drop in its stock price, closing at $382.99. Despite this decrease, ISRG is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum for the company.

The price of ISRG shares decreased by $6.41, or 1.65%, since the market last closed. However, in after-hours trading, the stock has risen by $0.91, showing some potential for recovery.

Investors and analysts will be keeping a close eye on ISRG in the coming days to see if the stock can maintain its upward momentum and continue to perform well. With its position near the top of its 52-week range, ISRG may have the potential for further growth and profitability in the future.

Overall, while the drop in ISRG’s stock price on March 13 may be concerning to some investors, the company’s strong price momentum and position above its 200-day simple moving average suggest that there may still be opportunities for growth and success in the future.

Intuitive Surgical Inc. (ISRG) Stock Performance Analysis: Strong Revenue Growth and Increased Net Income for 2024

On March 13, 2024, Intuitive Surgical Inc. (ISRG) stock showed strong performance based on the latest financial data. The company reported total revenue of $7.12 billion for the past year, which represents a 14.49% increase compared to the previous year. In the fourth quarter alone, ISRG generated $1.93 billion in revenue, marking a 10.59% increase from the previous quarter.

Net income for ISRG was reported at $1.80 billion for the past year and $606.20 million for the fourth quarter. This indicates a significant 35.98% increase in net income compared to the previous year. However, net income remained flat compared to the previous quarter.

Earnings per share (EPS) for ISRG were reported at $5.03 for the past year and $1.69 for the fourth quarter. This represents a 37.72% increase in EPS compared to the previous year, but EPS held flat compared to the previous quarter.

Overall, ISRG stock showed positive performance on March 13, 2024, with strong revenue growth and significant increases in net income and earnings per share compared to the previous year. Investors may view these financial results as a positive indicator of the company’s financial health and potential for future growth.

Tags: ISRG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Trading online

Inventiva to Unveil Results of LEGEND Phase IIa Trial on Lanifibranor and Empagliflozin Combination Therapy

DrugRetailers Trading online

Leadership Changes at Fossil Group Inc A Strategic Shift Towards Growth and Transformation

scPharmaceuticals Reports Strong Fourth Quarter 2023 Financial Results

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com